ScholarIQanswers from OpenAlex & ORCID
Xiangmei Chen
ResearcherPublications, citations & collaboration network
Xiangmei Chen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Xiangmei Chen have?
ScholarIQindexed works
Xiangmei Chen has 835 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Xiangmei Chen have?
ScholarIQcitation count
Xiangmei Chen has 16,558 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Xiangmei Chen?
ScholarIQh-index
Xiangmei Chen has an h-index of 64 in OpenAlex.
What is the i10-index of Xiangmei Chen?
ScholarIQi10-index
Xiangmei Chen has an i10-index of 389 in OpenAlex.
What is the ORCID of Xiangmei Chen?
ScholarIQorcid
The ORCID for Xiangmei Chen is on the source record.
What is the OpenAlex record for Xiangmei Chen?
ScholarIQopenalex
The OpenAlex for Xiangmei Chen is on the source record.
What are the most-cited papers on Xiangmei Chen?
ScholarIQmost cited works
IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway
Ming Bai, Li Zhang, Bo Fu, Jiuxu Bai, Yingjie Zhang, Guangyan Cai, Xueyuan Bai, Zhe Feng, Shiren Sun, Xiangmei Chen
Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis
Wei Zhang, Ming Bai, Yan Yu, Lu Li, Lijuan Zhao, Shiren Sun, Xiangmei Chen
Single-Cell Transcriptomics Reveal Immune Mechanisms of the Onset and Progression of IgA Nephropathy
Ying Zheng, Ping Lü, Yiyao Deng, Lu Wen, Yong Wang, Xin Ma, Zhongxin Wang, Lingling Wu, Quan Hong, Shuwei Duan, Zhong Yin, Bo Fu, Guangyan Cai, Xiangmei Chen, Fuchou Tang
Efficacy and Safety of Abelmoschus manihot for Primary Glomerular Disease: A Prospective, Multicenter Randomized Controlled Clinical Trial
Li Zhang, Ping Li, Changying Xing, Jiuyang Zhao, Yani He, Jianqin Wang, Xiongfei Wu, Zhangsuo Liu, Aiping Zhang, Hongli Lin, Xiaoqiang Ding, Aiping Yin, Yuan Fa-huan, Ping Fu, Li Hao, Lining Miao, Rujuan Xie, Rong Wang, Chunhua Zhou, Guangju Guan, Zhao Hu, Shan Lin, Chang Ming, Miao Zhang, HE Li-qun, Changlin Mei, Lı Wang, Xiangmei Chen
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial
Hiddo J.L. Heerspink, Rajiv Agarwal, George L. Bakris, David Z.I. Cherney, Carolyn S.P. Lam, Brendon L. Neuen, Pantelis Sarafidis, Katherine R. Tuttle, Christoph Wanner, Meike Brinker, Sara Dizayee, Peter Kolkhof, Patrick Schloemer, Paula Vesterinen, Vlado Perkovic, for the FIND-CKD investigators, Julio Bittar, Cesar Javier Zaidman, Natalia Cluigt, Miguel Hominal, Paola Aguerre, Fernando Halac, Elizabeth Gelersztein, M. Arriola, Rafaël Maldonado, Mariano Chahin, David Packham, Darren J. Lee, Eugenia Pedagogos, Celine Foote, Sunil V. Badve, Carmel M. Hawley, Jenny Chen, Nicholas A. Gray, Marijn M. Speeckaert, Laura Labriola, Peter Doubel, Bart Maes, Kathleen Claes, Bernard Dubois, Irena Dimitrova, Tsvetelina Vutova, Stefan Ilchev, Svetla Stamova, Yordanka Ivanova, А М Васильева, Xiangmei Chen, Shuifu Tang, Xudong Xu, Bi‐Cheng Liu, Weiming He, Yani He, Fang Liu, Caili Wang, Lianhua Chen, Jianying Niu, Deguang Wang, Ping Luo, Yuou Xia, Gengru Jiang, Qun Luo, Fang Wang, Menghua Chen, Hongli Lin, Rui Yan, Yinan Li, Qinkai Chen, Junwu Dong, Fei Xiong, Haibo Long, Hong Cheng, Yuehong Li, Juan Du, Fanna Liu, Qingping Chen, Wanhong Lu, Chaosheng Chen, Jianqin Wang, Lei Liu, Min Yang, Gang Long, Yongjun Shi, Wenge Li, Xiangdong Yang, Aicheng Yang, Jianfei Li, Xiaoyan Meng, Martin Prázný, Lucie Hornova, Petr Bucek, Mária Majerníková, Jan Wirth, Jitka Řehořová, Mads Hornum, Jesper Nørgaard Bech, Morten Lindhardt, Ditte Hansen, Line Mortensen, Claus Bogh Juhl, Ioannis Boletis